European Pharmaceutical Review

NOVEMBER 16, 2023

To support biosimilar adoption and expand access for patients in Europe, measures must be taken to reduce the cost of developing biosimilars” Since their introduction in 2006, biosimilars have generated more than €30 billion in cumulative savings for European healthcare systems as of 2022, an IQVIA report from last year highlighted.

Marketing 110

Marketing Education Competition Consulting 110

pharmaphorum

DECEMBER 12, 2022

” Anderson joined Roche’s Genentech division in 2006 as head of its immunology and ophthalmology business unit, after nine years at Biogen that culminated in a two-year stint as head of neurology. “He has been instrumental in shaping Roche’s transformation and I wish him all the best for the future.”

Pharma 95

Pharma Management Pharmaceutical Marketing 95

pharmaphorum

JANUARY 9, 2023

The transaction will be effected by means of a UK scheme of arrangement under Part 26 of the UK Companies Act 2006, subject to approval of Amryt shareholders, sanction by the High Court of Justice of England and Wales, and other customary closings, including regulatory/antitrust approvals.

Pharma 98

Pharma Biopharma Management Medicine 98

World of DTC Marketing

JUNE 4, 2021

A 2006 report by the Institute of Medicine helped establish how the rise in obesity among kids corresponds to the increased marketing of unhealthy food and drinks to them. Sugary, oily foods are engineered to be consumed often and in big portions. But we’re not just influenced by their irresistible taste.

Food 207

Food Insurance Leads Medical 207

PM360

MARCH 24, 2023

In 2006, Facebook boomed in mainstream popularity and MySpace was one of the most visited websites. Within the past 40 years, 202 new awareness days were introduced to Congress—71% of these were introduced after 2005. This is right around the time social media was really taking off.

Media 92

Media Education Pharma Networking 92

Pharmaceutical Technology

JULY 29, 2022

Janssen’s Risperdal (risperidone), a second-generation antipsychotic , got its first FDA approval for autism-related irritability for children over the age of five, in 2006.

Side effects 105

Side effects Medical Pharmaceutical Management 105

The Brooks Group

FEBRUARY 23, 2009

These nominations follow TBG's 2006 win as Consulting Sales Organization of the Year. They also mark the fifth time since 2006 that The Brooks Group has been tapped for recognition of one of their flagship training and coaching programs. We congratulate all of the Finalists on their achievement."

Recruitment 40

Recruitment Sales Sales process Sales Management 40

The Brooks Group

FEBRUARY 23, 2009

These nominations follow TBG's 2006 win as Consulting Sales Organization of the Year. They also mark the fifth time since 2006 that The Brooks Group has been tapped for recognition of one of their flagship training and coaching programs. We congratulate all of the Finalists on their achievement."

Recruitment 40

Recruitment Sales Sales process Sales Management 40

pharmaphorum

DECEMBER 28, 2022

In addition, she worked as head of inspectorate and licensing for the MHRA from 2004-2006. She joined NSF in 2017. The post How to get acquisition ready – a seller’s guide to merger and acquisition in pharma appeared first on.

Pharma 119

Pharma Pharmaceutical manufacturing Pharmaceutical Manufacturing 119

pharmaphorum

SEPTEMBER 30, 2022

First launched in 2006, sales of Januvia and its line extensions have remained reasonably strong despite increasing pressure in the type 2 diabetes market and price pressures, particularly in international markets. billion in the first half of 2022.

Marketing 59

Marketing Sales Competition FDA 59

Pharmacy Times

APRIL 11, 2023

State-level respiratory syncytial virus hospitalization rates for 2022 could be the highest seen since 2006, analysis published in Frontiers in Pediatrics indicate.

29

29

European Pharmaceutical Review

JANUARY 18, 2024

billion by 2023, driven by the launch of Merck’s Belsomra and Eisai’s lemborexant (E-2006). GlobalData’s Analyst covering Neurology and Ophthalmology, Thomas Parker, MPharmacol, predicted that Belsomra would lead the market by 2023.

Marketing 98

Marketing Sales Pharmacology Pharma 98

pharmaphorum

NOVEMBER 9, 2022

Lutz Bonacker joined CSL Behring in 2006 as Head of Global Commercial Development Coagulation and was promoted to his current position in 2015. About the author. He is responsible for the management of 14 European affiliates in the achievement of their sales goals and business objectives.

Management 98

Management Patients Sales goal Medical 98

European Pharmaceutical Review

AUGUST 23, 2022

World Health Organization; 2006. References. Counterfeit medicines. Available from: [link]. The Guardian. Fake drugs kill more than 250,000 children a year, doctors warn. 2019; Available from: [link]. Bitter Pills: The Global War on Counterfeit Drugs: Oxford University Press; 2018.

Medicine 98

Medicine Food and Drug Administration Pharmaceutical products Pharmaceutical 98

Contrarian Sales Techniques

DECEMBER 14, 2022

Anderson joined Genentech in 2006. Last week, Tecentriq, a Roche immuno-oncology drug, failed in a phase 3 trial for patients with advanced lung cancer. This was another setback for the company's multiple cancer drug combinations. He became the company's chief marketing officer in 2013.

Sales 52

Sales Pharmaceutical Marketing Patients 52

Pharmaceutical Technology

FEBRUARY 3, 2023

A partial change in perspectives The RV144 trial that took place between 2003 and 2006 in Thailand r eported modest efficacy results , which generated enthusiasm for vaccines that induce responses from non-neutralising antibodies, says Montefiori.

Medicine 117

Medicine Prospecting Safety Manufacturing 117

European Pharmaceutical Review

MARCH 6, 2023

Since 2006, he has held leadership positions in the neuroscience area at Eli Lilly and in epidemiology at GlaxoSmithKline. He joined Eisai in 2018 as Vice President, Clinical Research for the company’s Epilepsy and Sleep/Wake therapeutic areas.

Food and Drug Administration 96

Food and Drug Administration Safety Medicine Pharmaceutical 96

Pharmaceutical Technology

MARCH 22, 2023

Pfizer was the first to use the tech, adding RFID tags to track a Viagra (sildenafil) shipment circa 2006. The pharmaceutical industry began using radio frequency identification (RFID) tags in the early 2000s. Various uses soon became apparent including those for supply chain management, anti-counterfeiting, and to improve patient safety.

Food and Drug Administration 105

Food and Drug Administration Electronics Pharma Pharmaceutical products 105

European Pharmaceutical Review

SEPTEMBER 21, 2023

A physician specialised in otolaryngology and head and neck surgery by training, Since starting his pharmaceutical industry journey in 2006, he has acquired extensive medical affairs and clinical development experience across various therapeutic areas, both in rare diseases and more prevalent conditions, such as diabetes and heart failure.

Pharmaceutical 96

Pharmaceutical Food and Drug Administration Medicine Patients 96

The Brooks Group

NOVEMBER 1, 2007

2006 was a record-shattering year for sales and to ice the cake; Selling Power Magazine honored The Brooks Group as "Sales Consulting Organization of the Year." Through Bill's illness The Brooks Group has proved vibrant and successful, perhaps more so than ever.

Sales 40

Sales Consulting Management 40

pharmaphorum

AUGUST 4, 2022

In addition, she worked as head of inspectorate and licensing for the MHRA from 2004-2006. She joined NSF in 2017. The post How can the pharma industry address the gap in talent recruitment and development? appeared first on.

Recruitment 98

Recruitment Training Pharma Pharmaceutical manufacturing 98

Pharmaceutical Technology

APRIL 19, 2023

Following Bayer’s takeover of Schering Healthcare in 2006, where it inherited the oral contraceptive Yasmin (ethinyl estradiol + drospirenone) and the intrauterine device Mirena (levonorgestrel-releasing system), the German drugmaker has become one of the world’s leading pharmaceutical specialists in women’s health.

Healthcare 52

Healthcare Healthcare Leads Pharmaceutical 52

pharmaphorum

JANUARY 24, 2023

The cost of testing per human genome in 2006 was approximately $14 million , and in less than two decades, an average consumer-purchased genetic test costs $100. Though instances of this kind of therapy are rare, it is a growing area.

Food and Drug Administration 98

Food and Drug Administration Pharma Medicine Healthcare 98

PM360

SEPTEMBER 28, 2022

Chrys Kokino has been involved in the biosimilars market prior to the first biosimilar being approved in Europe in 2006. From that point in 2006 all the way to where we are currently today, there has been a very dramatic evolution of these products. And it really all attests to one word: education.

Competition 98

Competition Marketing Manufacturing Biopharma 98

pharmaphorum

JULY 6, 2022

He accepted the companies’ position that the painkillers they supplied – some 51 million between 2006 and 2014 – were shipped “in good faith” by the distributors before being prescribed by physicians and dispensed by pharmacies, and they had no way of telling whether those prescriptions were legitimate.

Doctors 59

Doctors Prescription Manufacturing Marketing 59

CloserIQ

OCTOBER 10, 2018

Founded 2006. Founded 2006. Founded 2006. The company has a “work hard, play hard” culture that emphasizes employees’ ownership over their work. Drift is a good fit for ambitious sales professionals and is searching for people to fill sales roles. 251-500 employees. in VC funding, $150M raised at IPO. See open roles. Revulytics.

Sales 76

Sales Management Education Marketing 76

Clarivate

APRIL 24, 2023

The drug store entered the retail clinic business in summer 2006 by acquiring Minneapolis-based MinuteClinic, an already-established chain of retail-based healthcare clinics with many locations inside CVS pharmacies. CVS’ bid for Oak Street is in keeping with nearly two decades of evolution toward becoming an integrated payer and provider.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

pharmaphorum

OCTOBER 13, 2022

Until July of 2006, Mr. Baxter was SVP, R&D Finance and Operations, of GlaxoSmithKline (GSK). Jeff Baxter – President and CEO, VBI Vaccines. Mr. Baxter joined VBI in September of 2009. Previously, he was a managing partner for the venture capital firm, The Column Group.

Management 52

Management Pharma Consulting Leads 52

European Pharmaceutical Review

DECEMBER 19, 2022

European regulators have led the way for the development of biosimilars in the past, with 86 approvals granted since 2006″ European regulators have led the way for the development of biosimilars in the past, with 86 approvals granted since 2006.

Medicine 52

Medicine Biopharma Safety Food 52

Clarivate

NOVEMBER 10, 2022

The evidence standards that a COA must meet to support key clinical trial endpoints have become increasingly stringent in recent decades, following the introduction of the United States Food and Drug Administration (FDA) Patient Reported Outcomes (PRO) draft guidance in 2006, followed by the full guidance in 2009.

Patients 52

Patients Food and Drug Administration FDA Safety 52

Pharmaceutical Technology

MARCH 24, 2023

Currently, 40 biosimilars are FDA-approved and 25 have launched, whereas the EMA has approved 86 biosimilars since 2006. The US biosimilars market is notably underdeveloped and biosimilar entry in the US has been difficult, consistently lagging behind Europe.

Competition 59

Competition Marketing FDA Physicians 59

PM360

MARCH 7, 2023

He was named the 2019 Industry Person of the Year by Med Ad News ; MM+M’s Entrepreneur of the Year (2018); a PM360 ELITE 100 Transformational Leader (2017); and made two appearances in PharmaVoice’s top 100 (2006, 2015). And in 2022, Calcium was named on MM+M’s Best Places to Work list.

Education 52

Education Healthcare Healthcare Pharma 52

Pharmaceutical Technology

FEBRUARY 24, 2023

The post Sweeping changes in leaked EU pharma law draft reignite profit vs access conflict appeared first on Pharmaceutical Technology.

Pharma 64

Pharma Medicine Competition Marketing 64

European Pharmaceutical Review

DECEMBER 20, 2023

cited 2023Dec] Available from: [link] pdf The post EU pharmaceutical legislation revisions: what are the implications for biopharma? appeared first on European Pharmaceutical Review.

Biopharma 98

Biopharma Pharmaceutical Medicine Manufacturing 98

Healthcare Success

JULY 5, 2022

Editor’s Note: I wrote the first version of this blog post back in 2006 when we launched Healthcare Success. How to create marketing and lead generation systems that get results. By Stewart Gandolf, MBA. While I intentionally wrote it with a quick, playful tone, more than sixteen years later, it remains one of our most popular posts.

Doctors 57

Doctors Physicians Marketing Healthcare 57

European Pharmaceutical Review

NOVEMBER 4, 2022

2006 [cited 7 September 2022];17(5):735-749. Colin received his MA in Economics and Management Studies from the University of Cambridge, UK, and his MBA from Stanford University, US. References. Hennenfent K, Govindan R. Novel formulations of taxanes: a review. Old wine in a new bottle? Annals of Oncology [Internet]. Available from: [link].

Food and Drug Administration 98

Food and Drug Administration Pharmaceutical FDA Patients 98

eMediWrite

AUGUST 30, 2023

To ensure prompt payments to MSMEs, strict implementation of current legislation is required, such as the Micro, Small, and Medium Enterprises Development (MSMED) Act, 2006. Government initiatives are crucial for fostering change. To discourage the use of delayed payment procedures, penalties for non-compliance should be implemented.

Pharma 52

Pharma Government Pharmaceutical Electronics 52